top of page
< Back

Rifaximin


Mechanism of action:

Rifaximin is a rifamycin antibiotic. Rifaximin binds with high affinity to the beta subunit of bacterial RNA polymerase, blocking the initiation of RNA elongation. As a result, mRNA cannot be produced, and all protein synthesis is inhibited.

Reference(s):

1. Cottreau J et al. (2010). Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections. Expert Rev Anti Infect Ther. 


2. Williams R et al. (2005). Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety. Rev Gastroenterol Disord. 


3. Koo HL et al. (2010). Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol.

bottom of page